KLRC1 and Salla disease: SD patients display increased clusters of NK-cells expressing the inhibitory receptors LILRB1 and NKG2A and non-proliferating NK-cells expressing NKp44, NKp46 and NKG2D and NKG2A (Fig. 6f–h, respectively clusters 8 and 10).